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Synopsis ...•..••.............•.••••.•..••••• 
Because of the enormity of the HIV-AIDS epidemic 
and the urgency for preventing transmission, HIV 
THE GLOBAL HIV-AIDS EPIDEMIC continues to ex-
pand rapidly. In the United States alone, as of 
December 1993, more than 360,000 persons were 
reported diagnosed with AIDS. The death toll has 
been more than 220,000 (1). In 1992, HIV infection 
became the leading cause of death among men ages 
25 to 44 and the fourth leading cause of death among 
women in the same age group (2). As of 1992, the 
cumulative costs for treating all persons with HIV 
infection in the United States were estimated to be 
$10.3 billion and were expected to increase to ap-
proximately $15.2 billion by 1995 (3,4). Governmen-
tal and nongovernmental organizations, local commu-
nities, researchers and advocates, and individual 
citizens together have responded to the epidemic by 
designing and implementing numerous programs to 
help people change behaviors that put them at risk of 
acquiring or transmitting HIV infection. 
HIV prevention programs should be evaluated 
systematically so that program managers and policy 
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prevention programs are a high priority for careful 
and timely evaluations. Information on program 
effectiveness and efficiency is needed for decision-
making about future HIV prevention priorities. 
General characteristics of successful HIV preven-
tion programs, programs empirically evaluated and 
found to change (or not change) high-risk behaviors 
or in need of further empirical study, and economic 
evaluations of certain programs are described and 
summarized with attention limited to programs that 
have a behavioral basis. 
HIV prevention programs have an impact on 
averting or reducing risk behaviors, particularly 
when they are delivered with sufficient resources, 
intensity, and cultural competency and are based on 
a firm foundation of behavioral and social science 
theory and past research. Economic evaluations have 
found that some of these behaviorally based pro-
grams yield net economic benefits to society, and 
others are likely cost-effective (even if not cost-
saving) relative to other health programs. Still, 
specific improvements should be made in certain HIV 
prevention programs. 
makers can make program decisions based on 
empirical findings rather than subjective impressions, 
and program utility and quality can be ensured (5,6). 
In 1994, HIV prevention programs underwent a 
special reexamination. Not only is the role of HIV 
prevention being discussed within the context of 
health care reform, but a shift is occurring toward 
more comprehensive community participation in 
shared decision making about HIV prevention efforts. 
For example, in 1994, the Centers for Disease 
Control and Prevention (CDC) formally introduced 
community planning as an essential component of its 
program support for HIV prevention programs at 65 
local, State, and Territorial health department levels. 
This type of planning requires HIV-AIDS epidemio-
logic surveillance and other data, ongoing program 
experience, program evaluations to date, and a 
comprehensive, objective needs assessment process. It 
incorporates the perspectives of groups at risk of 
acquiring or transmitting HIV infection for whom the 
programs are intended, providers of HIV prevention 
services, and scientific experts in the planning 
process (7,8). In addition, CDC's Advisory Commit-
tee on the Prevention of HIV Infection completed an 
external review of CDC's HIV prevention program 
and recommended substantial programmatic changes 
in its five major components (9, 10). Community-
based, governmental, and other organizations need 
detailed evaluative information to make sound deci-
sions about future program priorities and strategies. 
We attempt to contribute to this special reexamina-
tion of HIV prevention programs by addressing three 
timely questions. 
I. What are the general characteristics of HIV 
prevention programs that have a favorable impact on 
behavioral outcomes? 
2. Which specific HIV prevention programs have 
been found to have a favorable (or an unfavorable) 
impact on behavioral outcomes, and which are high 
priorities for further evaluation? and, 
3. Are the financial costs of behaviorally based 
HIV prevention programs outweighed by the 
economic benefits, and are these programs cost-
effective? 
We intend this paper to be a general overview and 
discussion of these three questions. We believe the 
HIV prevention literature discussed in this paper 
accurately and fairly reflects the current state of the 
field. It is beyond the scope of this paper, however, 
to include every possible citation. Readers who wish 
to compile a truly exhaustive bibliography should 
consult our reference list as well as those in the 
review papers cited and clearly identified. Neither is 
this paper a meta-analysis. The limited number of 
evaluation studies of specific types of HIV prevention 
interventions, use of different research methods, and 
diverse intervention designs and implementations 
render a formal quantitative meta-analysis problem-
atic at this time. 
Characteristics of Successful Programs 
We reviewed previously published (or readily 
available) lists of general characteristics of success-
ful, behaviorally based HIV prevention programs 
(11-28) and extracted several common elements that 
are briefly described. "Successful" is defined here as 
averting or reducing HIV -related risk behaviors or 
favorably modifying their determinants ("effective-
ness"), or both, and doing so at a minimal, cost-
effective or cost-beneficial level of resource invest-
ment ("efficiency," a broader-than-usual definition 
of this term). 
Basis in real specific needs and community plan-
ning. HIV prevention programs must address the real 
and expressed HIV prevention needs of the com-
munity being served, lest the program be rejected by 
the community as inappropriate, superfluous, and a 
waste of scarce resources. Needs should be consid-
ered at both the community and individual client 
level. For instance, a needs assessment may uncover 
a gap in HIV street outreach services for injection 
drug users (IDUs) in a given community and in the 
priority given to filling this community-level need. 
Individual clients receiving outreach services may 
have quite disparate specific needs, however. For 
example, some clients may need assistance recogniz-
ing their risk for HIV infection, while others may 
recognize their risk but need assistance obtaining 
risk-reduction counseling services. Communities and 
individual clients should not be considered merely 
respondents to a needs assessment but full partners in 
a shared decision-making process about which HIV 
prevention services are most needed (11,23,29). 
Cultural competency. To be successful, HIV preven-
tion messages must be tailored to the audience and its 
needs (11,23,29). Messages, at the very least, must be 
(a) sensitive to the particular culture of the audience, 
broadly defined to include age, educational level, sex, 
geography, race-ethnicity, sexual orientation, values, 
beliefs, and norms, and other factors; (b) appropriate 
to the developmental status of the audience, for 
instance, messages designed for middle-school stu-
dents are likely to be rejected by high-school 
students; and, (c) linguistically specific, which goes 
beyond using the same language as the audience. 
Clearly defined audiences, objectives, and inter-
ventions. A general principle of program planning 
and evaluation is that programs should have clear 
goals, objectives, and strategies (11,23,30). The 
principle includes a statement of the intended client 
subpopulation for each HIV prevention service being 
offered, process (service delivery) and outcome 
(behavioral or health) objectives, and specific inter-
ventions and their components (31). Without these 
statements, the program's design, implementation, 
and evaluation will lack direction and focus. 
Basis in behavioral and social science theory and 
research. The large and rapidly expanding literature 
on behavioral and social science theory and empirical 
findings relevant to changing HIV -related risk be-
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haviors was recently reviewed (11-13,15,21,23,25-
28,32-35). Kelly and coworkers (13) reviewed 
available (true-, quasi-, and non-experimental) studies 
of the behavioral consequences of HIV prevention 
interventions. They described three different types of 
relatively successful interventions--cognitively based, 
one-on-one interventions, community-level interven-
tions, and community mobilizations. Fisher and 
Fisher reviewed AIDS risk-reduction interventions 
from 1980 to 1990 and concluded that conceptually 
based, group-specific interventions focusing on infor-
mation, motivation, and behavioral skills were most 
successful in changing high-risk behaviors (21). Choi 
and Coates published a population-by-population 
categorization of evaluation studies of HIV preven-
tion behavioral outcomes (25). 
The National Commission on AIDS behavioral and 
social sciences report described eight factors needed 
for a person to lower his or her risk of HIV infection 
(12). 
I. strong intention to implement the risk-reduction/ 
avoiding behavior; 
2. no environmental barriers blocking the behavior 
change; 
3. necessary skills to execute the behavior change; 
4. perceived "pros" of the new behavior greater 
than the "cons;" 
5. perception that peers encourage the behavior 
change; 
6. consistency of one's self-image with the new 
behavior; 
7. perception that the new behavior is positively 
reinforced; and, 
8. belief that one can actually perform the new 
behavior. 
These factors have been empirically confirmed as 
important for averting or reducing HIV -related risk 
behaviors (12). The fifth factor emphasizes the utility 
of peer-delivered programs for changing group 
norms, and the seventh factor involves the psycholog-
ical principle of positive reinforcement for risk-
reduction behavior. Positive reinforcement deals with 
supporting and rewarding successive approximations 
to the desired behavior change (36). This is a 
sequential, dynamic process between the person 
changing his or her behavior and the reinforcer 
(perhaps a service provider, peer, or family member). 
Hence, long-term, lasting behavior change with one-
time HIV prevention interventions should not be 
routinely expected (although this will happen for 
some persons). Intensive and sustained interventions 
are needed (25). 
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Quality monitoring and adherence to plans. HIV 
prevention programs must be subjected to careful 
process evaluation to ensure that services are 
delivered according to plan (30). Service quality can 
be assured by using such measures as client satis-
faction and assessment of the content and manner of 
service delivery. Program costs should be measured 
or estimated to ensure that the program is on budget 
and the percentage distribution of the line items is as 
expected. 
Use of evaluation findings and mid-course correc-
tions. Successful HIV prevention programs must be 
monitored to determine if the stated outcome 
(behavioral or health) objectives are being ap-
proached (11,30). If not, then either the outcome 
objectives should be rechecked for reasonableness, or 
mid-course corrections should be made to the 
program itself to reach its objectives. Because of 
resource limitations, not every HIV prevention 
program can be subjected to scientifically rigorous 
outcome evaluation. This is not necessary, however, 
if empirical demonstrations exist (perhaps from other 
settings) that the program can achieve the desired 
behavioral or health outcomes and the program itself 
uses careful process evaluation to ensure that services 
are delivered according to plan (29). 
Sufticient resources. HIV prevention programs re-
quire sufficient financial, human, material, and 
temporal resources to achieve their goals and 
objectives (11). They must either procure sufficient 
resources enabling them to reach their desired goals 
and objectives or restructure their goals and objec-
tives to meet available resources. 
Programs to Change Risk Behaviors 
We review separately HIV prevention programs 
designed for persons presently at no or low risk for 
HIV infection (for example, information and educa-
tion programs to enhance their knowledge, attitudes, 
and beliefs regarding HIV and AIDS) and persons 
who are either HIV infected or HIV seronegative but 
engaging in high-risk behaviors (for instance, infor-
mation, education, counseling, and skills training 
programs to change their drug use and sexual 
practices). A comprehensive description of the 
multiple studies (and concomitant methodologies) of 
behavioral outcomes for each program for each group 
is not possible. Rather, we describe highlights and 
reviews of the evaluation literature and refer to more 
comprehensive reference sources and specific empiri-
cal investigations wherever possible. 
The references cited were found by multiple, 
electronic literature searches, reference tracing, and 
professional networking. Attention is limited to HIV 
prevention programs with a behavioral basis, as 
contrasted with purely technological or biomedical 
interventions, and almost exclusively to domestic 
studies (contrasted with research in developing 
countries) and published or readily available sources. 
The citations include studies with both favorable and 
unfavorable behavioral outcomes, and most of the 
studies relied on self-reported behavior, although a 
few included biological markers as well. 
Persons at No or Low Risk for Infection 
Information dissemination. Publicly funded infor-
mation dissemination programs have led to an overall 
increase in basic HIV knowledge in the general 
population (24,37-41). Most striking is data from the 
National Health Interview Survey (NHIS), a proba-
bility sample of the United States population, which 
showed that basic knowledge of modes of HIV 
transmission increased greatly over the last several 
years (40,41). For example, among 42,726 adults 
queried for the 1991 NHIS, 95 percent responded 
''true'' to the statement, ''Any person with the AIDS 
virus can pass it on to someone else through sexual 
intercourse;" and 94 percent responded "true" to 
''A pregnant woman who has the AIDS virus can 
give it to her baby" (40). 
In addition, several studies showed that HIV 
education in the context of comprehensive, school-
based health education lead to important knowledge 
gains among school and college youth (24,42-47). 
For instance, Walter and Vaughan (47) described a 
randomized study of an AIDS risk-reduction program 
for urban high school students given in six class 
periods. At the 3-month followup, 477 intervention 
students displayed statistically significant knowledge 
gains relative to 390 comparison students. They also 
noted several other studies demonstrating knowledge 
gains in school-based HIV education programs. 
Attitude change. General attitude change messages 
have been developed relatively recently and delivered 
with less intensity than information dissemination 
programs. Perceptions of discrimination and stigma-
tization have been found to have an unfavorable 
impact on use of HIV prevention services and are 
cited as a reason to avoid learning one's HIV sera-
status (40,48,49). Presumably, they also lead to a 
continued demand for anonymous (rather than con-
fidential) HIV antibody testing in many areas (50). 
Therefore, HIV prevention messages specifically 
designed to address discrimination and stigmatization 
need expansion and careful evaluation. 
Reinforcement of existing no- or low-risk be-
haviors. Information on the impact of messages 
reinforcing existing no- or low-risk behaviors on the 
general adult population is sparse but available for 
youth in educational settings. Several studies showed 
that specific HIV prevention programs in educational 
settings delayed the onset of or reduced high-risk 
behaviors (43,47,51-54). This was especially true of 
HIV-AIDS education programs that possessed the fol-
lowing characteristics: (a) inform students how to 
avoid becoming infected, or if already infected, how 
to avoid infecting others; (b) develop students' 
interpersonal skills to help them avoid, cope with, or 
leave HIV-risk situations; (c) motivate students 
through peer presentations and support groups to use 
their newly acquired, HIV -relevant knowledge and 
skills; and, (d) allocate sufficient classroom hours 
(20-25 hours) to influence students' behaviors (43). 
These characteristics are consistent with Fisher and 
Fisher's conclusion that AIDS risk-reduction pro-
grams are most effective if they address information, 
motivation, and behavioral skills (21). 
A comprehensive review paper in this area (53) 
characterized effective, school-based HIV education 
programs for adolescents as those that 
1. use social learning theories for program 
development; 
2. focus on reducing sexual risk-taking behaviors 
that may lead to HIV -STD infections or unintended 
pregnancies; 
3. provide accurate, basic information about the 
risks of and methods for avoiding unprotected 
intercourse; 
4. address social or media influences on sexual 
behaviors; 
5. reinforce clear and appropriate individual and 
group values against unprotected intercourse; and, 
6. model and practice communication and negotia-
tion skills. 
Recent literature reviews (52,53) found that the 
discussion of HIV -related issues in schools does not 
spur the onset of sexual activity among youth. 
Since 1986, Switzerland has supported broad-based 
social marketing of condoms to curb the transmission 
of HIV infection, particularly among adolescents and 
young adults (55,56). From 1987 to 1990, this active 
promotion of condom use neither significantly in-
creased the proportion of adolescents engaging in 
sexual intercourse nor the average number of sexual 
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partners, but it did increase reported condom use 
markedly (56). Among young adults engaging in 
casual sex, the proportion using condoms every time 
also significantly increased (55). These results sug-
gest important lessons and research questions for HIV 
prevention efforts in the United States. 
Programs for Risky Behaviors 
Clearly, program goals, objectives, and strategies 
for averting or reducing high-risk behaviors among 
HIV seronegative and seropositive persons vary. HIV 
prevention programs often reach them long before 
their serostatus is known, however. For example, 
although prevention messages delivered to HIV 
seronegative and seropositive persons may differ, 
several modes of message delivery (like street 
outreach) are common for these two populations. 
Therefore, our review of behaviorally based HIV 
prevention programs for these high-risk groups is 
integrated in this paper. 
Counseling, testing, referral, and partner notifica-
tion (CTRPN). CTRPN programs, which include 
counseling designed to change HIV -related risk 
behaviors, have probably undergone more evaluation 
than any other HIV prevention program. Higgins and 
colleagues (57) reviewed the literature on behavioral 
consequences of HIV antibody counseling and test-
ing. They found that counseling and testing tended to 
reduce HIV -related risk behaviors in specific 
populations--especially among heterosexual couples 
discordant in HIV serostatus and (though slightly less 
obvious from the data) gay men testing HIV sero-
positive. For instance, researchers in four studies of 
discordant, heterosexual couples reported substantial 
increases in their consistent use of condoms after 
HIV antibody counseling and testing (57). 
Research on persons learning their HIV sero-
negativity in the context of counseling and testing has 
yielded mixed results (57-64). Several studies found 
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either little or no effect on high-risk behaviors for 
those aware of their own serostatus and in counseling 
(57,58,60,61), or a higher risk for those learning their 
seronegativity than those unaware or untested 
(57,59,63). One study found some risk reductions 
(62). Overall, little evidence supports the notion that 
HIV antibody counseling and testing for HIV sero-
negative persons (as implemented in these studies) 
lead to favorable behavior changes (64). The 
preponderance of evidence, however, shows the 
experience is not harmful for them either. For persons 
testing HIV seronegative, behavioral science theory 
and research suggest the need to strengthen the 
duration and intensity of counseling and other 
preventive services tailored to client-specific needs 
and the quality and suitability of delivering both 
counseling and testing services (65,66). 
Individual or group information, education, and 
counseling. Although HIV antibody testing should be 
delivered in the context of counseling (66), counsel-
ing is not always delivered in the context of testing. 
Sometimes stand alone counseling interventions have 
been used as comparative conditions to counseling 
and testing (62). Several studies evaluated one-on-one 
or small group, risk-reduction counseling interven-
tions completely unlinked to HIV antibody testing 
(for a comprehensive listing, see 25,53). Many of 
these studies were randomized, controlled trials 
examining behavioral outcomes (32,67-85). The 
preponderance of evidence from these trials suggests 
that behavioral interventions decreased risky drug- or 
sex-related activities (32,67,68,70,71,73,74,76-78,80-
84). 
Community-level. Kelly and coworkers (13,23) 
pointed to community-level interventions as promis-
ing for changing HIV-related risk behaviors. 
Community-level interventions are those that (a) 
target the community (often defined by sex, geogra-
phy, risky behaviors, race-ethnicity, or sexual orienta-
tion) rather than a specific individual; (b) involve 
community members in the actual design and delivery 
of the intervention; and (c) aim to change community 
norms about high-risk behaviors (as well as modify 
individual behaviors). Kelly and colleagues recruited 
opinion leaders from communities of gay men, 
trained them in HIV prevention messages and 
message delivery, and asked them to take these 
messages back to their communities. Carefully 
executed, controlled studies showed that this interven-
tion changed community norms and self-reported, 
risky sexual behaviors (13,23,86,87). 
For example, Kelly and coworkers (86) assessed 
the impact of using trained community members to 
endorse openly the importance and acceptability of 
changing sex-related risk behaviors among male 
patrons of gay bars in three southern communities. In 
one of the three communities, 295 gay men com-
pleted the pre- (intervention) surveys and 348 the 
post-intervention surveys. After introducing popular, 
behavior-change endorsers into this community of 
gay men, the mean percentage of gay men reporting 
unprotected anal intercourse during the preceding 2 
months decreased by 24 percent from mean baseline 
levels, self-reported use of condoms for all anal 
intercourse occasions increased by 15 percent, and 
the number of gay men reporting more than one sex 
partner decreased by 6 percent (86). 
Another large-scale, community-level intervention, 
the AIDS Community Demonstration Projects, oper-
ated in several American cities-Dallas, Denver, 
Long Beach, New York City, and Seattle-and ad-
dressed five priority populations-(a) men having sex 
with men, but not self-identifying as gay; (b) out-of-
treatment IDUs; (c) female sex partners of IDUs; (d) 
female prostitutes; and (e) youth in high-risk 
situations (youth neither at home nor in school) (17). 
In all cases, the projects used actual success stories of 
behavior change by one or more community mem-
bers, translated these stories into HIV prevention 
messages, trained community members in message 
delivery, and asked them to relay these messages to 
others. 
The projects pioneered the adaptation of Pro-
chaska's stage of behavior change model (88) to HIV 
prevention (17). This model posits that persons cycle 
(and relapse) through these stages of behavior 
change: 
1. pre-contemplation (unaware of own risk or do 
not intend to change the risk behavior "problem" in 
the near future); 
2. contemplation (seriously consider overcoming 
the ''problem,'' but make no commitment toward 
action); 
3. preparation (intend to take effective action in 
the very near future); 
4. action (modify behavior, environment, or ex-
perience to overcome the "problem"); and 
5. maintenance (stabilize the new behavior and 
avoid relapsing to the "problem") (88). 
The community members' success stories (already 
noted) were combined with the stage of behavior 
change framework (and other theoretical constructs) 
to craft messages specifically designed for community 
members at particular stages of behavior change, 
which was seen as central to maximizing the success 
of this intervention. Preliminary data analyses from the 
projects indicate greater movement toward consistent 
use of bleach for cleaning injection equipment or use 
of condoms during sexual intercourse for persons ex-
posed to this intervention than those not exposed (89). 
Outreach. Outreach programs aim to encounter 
clients in their own community who are unlikely to 
be receiving important HIV prevention services (90). 
They generally fall into two broad categories-those 
that refer clients to HIV prevention services offered 
in other settings or those that provide HIV prevention 
services in street or other nontraditional settings. 
Outreach programs encountering IDU clients have 
been intensively evaluated by the National AIDS 
Demonstration Research (NADR) Project (91) and are 
described in the ensuing section. CDC launched a 
family of studies at eight sites to assess enhancements 
to existing street outreach services for IDUs and 
youth in high-risk situations. These studies have 
yielded interesting process evaluation and service 
delivery data, and the outcome evaluation phase 
began in 1993 (90). 
Drug treatment and other, related activities. The 
point of contact with IDUs (and their sex partners) has 
generally been as inpatients in a drug detoxification 
and rehabilitation program, outpatients in a drug 
treatment center, or out-of-treatment IDUs. Through a 
variety of information, education, and counseling 
sessions, HIV prevention programs have attempted to 
get IDUs to stop using and injecting drugs, stop using 
unclean needles and syringes, and stop engaging in 
high-risk sexual behaviors (35,67-69, 74, 75, 79,80,85, 
92-100). Whether offered early or late in the treatment 
process or as standard (short, one-time) or enhanced 
(longer, multiple) versions, these sessions generally 
reduced IDUs' risky drug behaviors (especially those 
needle-related). Their impact on modifying sex-related 
risk behaviors such as casual partners or exchanging 
sex for drugs or money was less obvious and requires 
further study (67-69,74,75,79,80,85,93,95,99,100). 
The NADR Project assessed longitudinal data from 
28 sites delivering street outreach services to a total 
of 13,475 IDUs and 1,637 sex partners of IDUs 
(91,93). Study participants were randomly assigned to 
standard or enhanced AIDS education and counseling 
sessions. At the 6-month followup, a clinically 
meaningful and statistically significant reduction was 
found for the following high-risk behaviors of IDUs 
for both intervention assignments: frequency of 
injecting drugs, use of noninjected drugs, use of 
borrowed injection equipment, and number of sex 
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partners. Twenty-eight percent fewer of the total IDU 
sample reported injecting daily at followup than at 
baseline (42 percent versus 70 percent). Twenty-four 
percent fewer reported borrowing needles at followup 
than at baseline (24 percent versus 48 percent) and 8 
percent fewer reported having two or more sex 
partners during the preceding 6 months (36 percent 
versus 44 percent). 
Furthermore, favorable behavior changes were 
found for use of new needles, bleach to clean 
injection equipment between uses, and condoms. 
Among the 13,475 IDUs, 21 percent more reported 
always using new needles at followup than at base-
line (40 percent versus 19 percent), and 9 percent 
more reported always using condoms (19 percent 
versus 10 percent). Several factors contributed to the 
favorable impact of street outreach services, including 
using outreach workers from the community (often 
ex-addicts), providing bleach and condoms and 
demonstrating their correct use, and offering training 
in sexual negotiation and refusal skills (91). 
Wiebel and colleagues (101) argued that their 
NADR program had a favorable impact on HIV sera-
incidence in three Chicago communities. They 
followed 641 out-of-treatment, initially HIV 
seronegative IDUs over a 4-year period. Without the 
street-based outreach program, the expected number 
of new HIV infections among these IDUs was 172; 
however, only 90 HIV conversions were estimated to 
have occurred largely because the percentage of IDUs 
engaging in risky drug behaviors (primarily sharing 
needles, syringes, and other injection equipment) 
decreased from 1 00 percent to 14 percent during the 
study period (101). 
Further research is needed to understand better (a) 
the culture(s) of drug users in our society (their 
beliefs, practices, and perceptions of risk) to know 
which specific HIV prevention programs could be 
most effective and efficient in affecting favorable 
drug- and sex-related behavior changes (93,100, 
102,103); (b) the various sub-groups among IDUs 
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defined by characteristics such as drug preference, 
ethnicity, and sex who likely require different types 
of drug treatment as well as HIV information, 
education, and counseling sessions in terms of 
content, duration, and format (91,99,100); and (c) the 
long-term impact of information, education, and 
counseling efforts on IDUs' HIV-related risk be-
haviors (91, 1 00). 
In addition, future research should determine the 
relative benefits of HIV information, education, and 
counseling sessions as well as the contribution drug 
treatment itself makes to HIV prevention. For 
instance, by reducing the frequency of drug use, 
methadone maintenance programs contribute to HIV 
prevention directly. 
Needle and syringe exchange. Presently, there are at 
least 37 needle and syringe exchange programs 
(NEPs) in the United States, with the first established 
in 1988 (104,105). NEPs primarily focus on reducing 
IDUs' drug use through referral to drug treatment and 
such high-risk drug behaviors as frequency of 
injection (often with the same needle), needle or 
syringe sharing, and use of unclean injection equip-
ment. Furthermore, attention is often devoted to 
reducing risky sexual behaviors such as number of 
sex partners, proportion of sex partners who are also 
IDUs, HIV prevalence in those partners selected, and 
unprotected intercourse (104,105). A recent study 
emphasized the continued need for available, sterile 
needles and syringes (106) . Among 466 IDUs 
interviewed, researchers found that 49.6 percent 
purchased needles and syringes on the street, 63.7 
percent possessed fewer than three sets of needles 
and syringes, and 88.6 percent reused needles and 
syringes (69.6 percent used a single set for three or 
more injections). Asked if they would use an NEP, 
88.2 percent of those interviewed responded affirma-
tively (106). 
Empirical evidence of the impact of domestic NEPs 
on IDUs' HIV-related risk behaviors is relatively 
scarce, although more data are becoming available 
(35,107). A recent comprehensive review reported that 
only 9 of 26 studies assessing the impact of NEPs on 
IDUs' high-risk drug and sexual behaviors were based 
in the United States (105). With respect to the 16 
"higher quality" studies, most of these studies found 
reductions in the frequency of injection (3 out of 8 
studies), frequency of needle or syringe sharing (10 
out of 14), and likelihood of giving away used needles 
(3 out of 5). Three out of four studies showed an 
increase in needle cleaning. Whether NEPs had an 
impact on IDUs' number and choice of sex partners 
and use of condoms was less obvious (105). 
Further research is needed to describe more fully 
(a) the social context and patterns of drug use in 
general and needle and syringe sharing in particular 
(including the "kinetics" of needles and syringes as 
they circulate through a group of IDUs) (102,105); 
(b) the long-term impact of NEPs on IDUs' HIV-
related risk behaviors (108); and (c) alternative 
methods for dispensing new, sterile needles and 
syringes to IDUs such as using local pharmacies 
(105). In addition, future research should evaluate the 
effect of any changes in drug paraphernalia and 
prescription laws on needle-sharing behaviors. 
Economic Evaluations of Programs 
There has been a renewal of the debate over 
whether prevention efforts save society money, or 
whether persons spared preventable illnesses accrue 
greater health costs given their extended lifetimes 
(109-111). One might question whether HIV and 
other disease prevention programs should be held 
accountable to the standard that a program's 
economic benefits to society should outweigh its 
financial costs. Whether or not one accepts this 
standard, applications of economic evaluation tech-
niques are as appropriate to behaviorally based HIV 
prevention programs as they are to other health 
programs. Even if an HIV prevention program does 
not actually save society money, it is possible the 
program is still cost-effective relative to other health 
programs. 
Holtgrave and co-workers (112,113) recently com-
pleted a thorough review of the economic evaluation 
literature relating to HIV prevention and treatment 
programs. Among 47 studies meeting their inclusion 
criteria, they found that most of these studies dealt 
with treatment and mandatory rather than voluntary 
prevention programs (especially certain screening 
strategies). We describe some of the major cost-
benefit and cost-effectiveness analyses from this 
review, along with other, more recently presented or 
published analyses. These descriptions serve to 
illustrate the current state-of-the-art of applying 
economic evaluation techniques to HIV prevention 
and the need for collecting program-specific cost and 
benefit (or effectiveness) data. Because the underly-
ing assumptions and methods used by researchers are 
not entirely common across studies, care should be 
exercised when comparing reported cost-benefit and 
cost-effectiveness results from different citations. 
Cost-benefit analyses. Holtgrave and co-workers 
conducted a cost-benefit analysis of publicly funded 
HIV CTRPN programs (64). It was assumed that 
CTRPN would not be provided without public fund-
ing and at least 20 new HIV infections were averted 
for every 100 HIV seropositive persons identified and 
reached by CTRPN (as described and justified in 
much greater detail in their article [64]). They 
estimated this program's direct and indirect costs, 
number of persons served, approximate number of 
HIV infections averted, monetary benefits to society 
for each HIV infection averted, and benefit-cost 
ratios. Under base-case assumptions, the benefit-cost 
ratio was slightly more than 20 (every dollar invested 
in HIV CTRPN yielded a $20 gain), and greater than 
one for all cases considered (64). 
The parameter of greatest uncertainty in the HIV 
CTRPN cost-benefit analysis was the quantitative 
effectiveness of service delivery in preventing HIV 
infection. Although the exact value of this parameter 
might be questioned, the threshold (or "break-
even") analysis showed that (under base-case as-
sumptions) even if only 1 in 100 persons testing HIV 
seropositive and receiving the associated counseling 
and referral services changed his or her behavior and 
averted transmission to one other person, the 
economic benefits of the program equalled the 
financial costs (64). Although it is difficult to state 
precisely the exact effect of an HIV prevention 
program on numerous outcome variables, it is 
relatively easy to demonstrate that, even if the 
favorable impact is quite small, the program can yield 
net economic benefits to society. Such analyses lend 
economic support to the concept that HIV prevention 
efforts need not change the behavior of every client 
in order to be worthwhile (114). 
Cost-effectiveness analyses. Owens and co-workers 
(115) recently evaluated the cost-effectiveness of 
CDC's recommendation to screen for HIV infection 
in acute care settings where the seroprevalence of 
HIV infection is 1 percent or more. When measuring 
only the costs and benefits associated with the person 
screened, the cost-effectiveness of screening was 
$60,000 per life year saved at 1 percent seropre-
valence, and ranged from $71,000 to $55,000 per life 
year saved at 0.5 to 2 percent seroprevalence (115). 
This cost per life year saved is near the cutoff usually 
considered cost-effective for screening strategies 
(116). These cost-effectiveness ratios appear less 
favorable than the cost-saving results for publicly 
funded HIV CTRPN (as described previously) be-
cause of the lower HIV seroprevalence of the acute-
care settings relative to the CTRPN sites and perhaps 
different study assumptions and methods (for other 
recent papers about HIV screening, see 117). 
As part of an assessment of the public health 
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HIV-AIDS Literature Review 
To represent the evaluation literature in a given topic 
area accurately and fairly, at least one scientific 
expert (not a co-author) for each area at the Centers 
for Disease Control and Prevention (CDC) and some 
at outside institutions reviewed an earlier draft (or 
sections thereof) of this paper. 
Paul Farnham and Robin Gorsky read the section 
describing economic evaluations of HIV prevention 
programs, and T. Stephen Jones reviewed the drug-
related sections. They are all with the Office of the 
Associate Director for HIV-AIDS, Office of the 
Director. 
Janet Collins of the Division of Adolescent and 
School Health, National Center for Chronic Disease 
Prevention and Health Promotion, read the section 
describing school-based HIV -AIDS education. 
Ron Wilson with the Office of Analysis, 
Epidemiology, and Health Promotion, National Cen-
ter for Health Statistics, reviewed the information 
dissemination section. 
Donna Higgins, Division of STD-HIV Prevention, 
National Center for Prevention Services, read the 
section describing counseling, testing, referral, and 
partner notification, and Daniel Schnell, of the same 
division, read the section on community-level 
interventions. 
Wanda Jones and Laura Leviton, Office of the 
Associate Director for HIV -AIDS, Lynda Doll of the 
Division of HIV -AIDS, National Center for Infec-
tious Diseases, and Sevgi Aral, Division of STD-HIV 
Prevention, reviewed multiple sections of the 
manuscript. 
James Kahn with the Institute for Health Policy 
Studies, University of California at San Francisco, 
and Mary Utne-O'Brien of the School of Public 
Health, University of Illinois at Chicago, read the 
specific sections describing their respective work 
with IDUs. 
Finally, Richard Needle with the Community 
Research Branch, National Institute on Drug Abuse, 
provided extensive background materials for the 
drug-related sections. 
impact of NEPs in the United States, researchers 
determined the cost-effectiveness of NEPs in prevent-
ing HIV infection. Using a simplified version of the 
New Haven needle circulation model, they estimated 
that in four hypothetical cities with varying organiza-
tional, program, and HIV -risk parameters, the cost 
per HIV infection averted among NEP clients ranged 
from $12,000 to almost $100,000 (118). Using a 
different model of HIV transmission and a synthesis 
of NEP behavior-change evaluations for only one of 
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the four cities, the cost per HIV infection averted was 
about $4,000 (118). Other cost-effectiveness measures 
derived to assess the productivity of NEPs included 
cost per client contact (ranging from $6 to $41 for 7 
NEPs reporting), cost per syringe distributed (ranging 
from $0.26 to $6.81 for 16 NEPs), and cost per 
(service) hour open (ranging from $4 to $550 for 16 
NEPs) (119). 
Another study estimated the cost-effectiveness of 
these five HIV prevention interventions for IDUs: 
counseling and testing, extended counseling and 
education (after counseling and testing), partner 
notification, bleach distribution, and treatment of drug 
dependency (120). For each intervention, the cost per 
adult HIV infection averted was calculated using only 
the direct costs associated with implementing the 
intervention in two sample cities in the eastern United 
States with moderate-to-high HIV risk levels. Cost 
per adult HIV infection averted for the first four 
interventions ranged from about $3,000 to $32,000 in 
City A and $4,000 to $66,000 in City B, with partner 
notification being the most expensive. Treatment of 
drug dependency provided additional HIV -related 
benefits of $5,000 to $7,000 per treatment slot per 
year (120). 
Wiebel and colleagues (101) concluded that street-
based outreach services (and use of indigenous 
outreach workers) were cost-effective alternative 
interventions for preventing HIV infection among 
IDUs. They estimated that a street outreach program 
in the Chicago area prevented 82 new HIV infections 
among 641 IDUs over a 4-year period, which would 
have cost more than $9.7 million to treat from 
infection to death. Under this program, the cost per 
individual IDU contact was $30, and the cost per 
HIV infection prevented ranged from $150 to $300 
(101). 
Summary 
The preponderance of the empirical evidence 
reviewed showed that behaviorally based HIV pre-
vention programs have a favorable impact on 
behavioral outcomes in specific populations, 
especially when delivered with sufficient resources, 
intensity, and cultural competency. In addition, of the 
programs examined by cost-benefit analysis, HIV 
prevention efforts need have only a small favorable 
impact on behavioral outcomes for the program's 
economic benefits to outweigh the financial costs. 
Although the relative cost-effectiveness of HIV 
prevention efforts is just now receiving attention, 
analyses to date indicate favorable results. Thus, there 
should be a strong, continued commitment of private 
and public funds to behaviorally based HIV preven-
tion programs. 
This overview (and good program management 
principles) suggests, however, that specific areas for 
HIV prevention program improvement include the 
following: 
1. modifying programs to meet as many of the 
general characteristics of successful programs as 
possible, 
2. emphasizing programs recetvmg favorable 
evaluations in future community planning priority 
settings for HIV prevention, 
3. redesigning or discontinuing programs receiving 
unfavorable evaluations, and 
4. devoting attention to programs needing high 
priority evaluative study (especially those serving 
populations disproportionately affected by the HIV 
epidemic). 
Other challenges remain in answering the following 
policy-related questions: 
1. What is the optimal amount of funding to 
expend on HIV prevention relative to other health 
programs? 
2. In terms of number of HIV infections averted, 
what is the optimal expenditure of HIV prevention 
funds for each subpopulation (for example, persons at 
no or low risk for HIV infection, high-risk but HIV 
seronegative, and HIV infected) and the programs 
associated with each? 
3. What are the optimal methods for delivering and 
supporting HIV prevention services? 
4. What is the optimal mix of various HIV pre-
vention interventions and services that results in a 
comprehensive HIV prevention program? and, 
5. How readily transferable are the behavioral 
outcomes of successful HIV prevention programs 
from one subpopulation or setting to another? 
Although answering this set of policy-related 
questions will provide difficult challenges in the 
future, the empirical evidence to date indicates that 
behaviorally based HIV prevention programs have a 
favorable impact on behavioral and economic out-
comes. Now is the time for a renewed commitment to 
HIV prevention efforts designed to change behaviors 
putting one at risk of acquiring or transmitting HIV 
infection. 
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